The journal Nature reported that German research discovered a potential solution – a “heart patch” made from stem cells that could provide a “bridge to transplantation, or maybe even a permanent fix.” MedicalBrief (24 April 2025)
Reuters reported on 24 April that major European pharmaceutical companies, including AstraZeneca, Novartis and Sanofi are intensifying calls for the European Union (EU) to permit higher medicine prices.
“A SA court ruled in favour of Adcock Ingram and Zambon SPA, ordering Cipla Medpro to stop using the trademark Furizome for its urinary tract infection (UTI) medication. The court found Furizome confusingly similar to the established Urizone trademark, leading to a ruling based on trademark infringement and unlawful competition. – HealthMatters (24 April 2025)
With President Cyril Ramaphosa being “too busy with the G20” and Health Minister Aaron Motsoaledi, “missing in action”, critics warn that the cost of doing nothing regarding the HIV treatment programme puts millions of lives at risk. – MedicalBrief (24 April 2025)